Summary
The National Institutes of Health (NIH) is soliciting applications under PAR-25-352 for the National Cooperative Drug/Device Discovery/Development Groups (NCDDG) program focused on the treatment of mental disorders. This is a U01 cooperative agreement mechanism with clinical trials optional. The program supports collaborative, multi-disciplinary research groups engaged in the discovery and development of novel drugs or devices targeting mental health conditions. The opportunity opened in January 2025 and accepts applications through October 2027, suggesting a multi-cycle funding announcement.